Drug Type Mesenchymal stem cell therapy |
Synonyms- |
Target- |
Mechanism Stem cell replacements |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Respiratory Distress Syndrome, Acute | Phase 2 | CN | 29 Mar 2024 | |
Dermatitis, Atopic | Phase 1 | CN | 14 May 2024 | |
Respiratory Distress Syndrome, Adult | Phase 1 | CN | 11 Oct 2023 |